Oxford BioMedica Announces Presentation at 27th Annual ROTH Conference

4 March 2015

Oxford, UK – 5 March 2015: Oxford BioMedica plc (LSE: OXB), (“OXB” or “the Company”) a leading gene and cell therapy company, announces that Tim Watts, Chief Financial Officer, will present a company overview on 9 March 2015 at the 27th Annual ROTH Conference at the Ritz Carlton Laguna Niguel, CA, US. The OXB presentation will begin at / 2pm PST / 5pm EST / 10pm GMT.

A simultaneous webcast of the presentation will be accessible at https://wsw.com/webcast/roth29/oxb.l

Following the presentation there will be an archived replay of the presentation available on the Company’s website.